經月經檢測市場規模、佔有率及成長分析（按產品類型、治療類型、最終用戶和地區）—產業預測，2025 年至 2032 年

2023 年全球經月經檢測市場規模為 36 億美元，預計將從 2024 年的 38.9 億美元成長到 2032 年的 72.6 億美元，預測期內（2025-2032 年）的複合年成長率為 8.1%。

由於月經盛行率的不斷上升、人們對月經健康的認知不斷提高以及診斷技術的進步，全球月經檢測市場正在經歷顯著成長。月經疼痛的廣泛影響導致尋求臨床評估的患者增加，從而增加了對檢測服務的需求。政府推出的支持性政策資助了月經衛生舉措，也增加了月經檢測的機會。生殖健康診所的增加和人們對不孕症治療的興趣日益濃厚，進一步促進了檢測需求的成長。此外，人工智慧和機器學習等技術創新有助於分析患者數據，以便在早期預測月經，而物聯網設備則有助於在月經期間持續監測生命徵象，最終改變月經診斷和管理的模式。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 顧客購買行為分析

經月經檢測市場規模（依產品類型及複合年成長率）（2025-2032）

• 市場概覽
• 原發性經痛檢查
• 續發性月經檢查

經月經檢測市場規模（依治療類型及複合年成長率）（2025-2032）

• 市場概覽
• 止痛藥
• 荷爾蒙療法
• 外科手術

經月經檢測市場規模（依最終用戶分類）及複合年成長率（2025-2032）

• 市場概覽
• 醫院和診所
• 研究中心

經月經檢測市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• Pfizer Inc.
• Bayer AG
• Johnson & Johnson Services, Inc.
• Quin
• Abbott Laboratories
• Merck & Co., Inc.
• Global Pharma plc
• Mylan NV
• Teva Pharmaceutical Industries Ltd.
• Proteomics Inc.
• Boehringer Ingelheim International GmbH
• Ferring Pharmaceuticals

結論和建議

Global Dysmenorrhea Testing Market size was valued at USD 3.6 billion in 2023 and is poised to grow from USD 3.89 billion in 2024 to USD 7.26 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global dysmenorrhea testing market is experiencing significant growth, driven by the increasing prevalence of dysmenorrhea, heightened awareness of menstrual health, and advancements in diagnostic technologies. More patients are seeking clinical evaluations due to the widespread impact of menstrual pain, which boosts demand for testing services. Enhanced access to dysmenorrhea testing is also attributed to supportive government policies that fund menstrual health initiatives. The rise in reproductive health clinics and a growing focus on fertility are further contributing to the uptick in testing. Additionally, innovations such as AI and machine learning help analyze patient data to predict dysmenorrhea early, while IoT devices facilitate continual monitoring of vital signs during menstruation, ultimately transforming the landscape of dysmenorrhea diagnosis and management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dysmenorrhea Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dysmenorrhea Testing Market Segments Analysis

Global Dysmenorrhea Testing Market is segmented by Product Type, Type of Treatment, End User and region. Based on Product Type, the market is segmented into Primary Dysmenorrhea Testing and Secondary Dysmenorrhea Testing. Based on Type of Treatment, the market is segmented into Pain Relievers, Hormonal Therapy and Surgery. Based on End User, the market is segmented into Hospitals and Clinics and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dysmenorrhea Testing Market

The rising prevalence of both primary and secondary dysmenorrhea, coupled with an increased inclination among women to seek healthcare for chronic or severe menstrual pain, is driving the demand for dysmenorrhea testing. As more individuals pursue clarity regarding their conditions, the need for accurate diagnostics becomes essential. Moreover, heightened awareness and advocacy from governmental bodies and non-governmental organizations focused on women's health further promote the importance of medical screenings for menstrual disorders. This growing emphasis on health and well-being ultimately contributes to a burgeoning market for dysmenorrhea testing solutions, reflecting a significant shift towards proactive healthcare management in this area.

Restraints in the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market faces significant challenges stemming from cultural stigmas surrounding menstruation, which often discourage open discussion and restrict access to necessary menstrual health services. In conservative societies, women frequently experience limitations on their autonomy, which can hinder their ability to pursue healthcare options or prioritize their well-being, particularly when their pain is minimized or dismissed. Moreover, there can be a tendency among healthcare providers to overlook or undervalue the symptoms reported by patients due to existing gender biases, ultimately detracting from the quality of care and the effectiveness of testing for dysmenorrhea.

Market Trends of the Global Dysmenorrhea Testing Market

The Global Dysmenorrhea Testing market is witnessing a significant upward trend driven by an increase in awareness surrounding menstrual health and the importance of early diagnosis. Government initiatives and nonprofit educational campaigns are effectively breaking the stigma associated with menstrual disorders, encouraging women to pursue dysmenorrhea testing and subsequent care. This heightened health awareness is propelling the demand for innovative testing solutions, including hormonal profiling, ultrasound diagnostics, and advanced deep learning scans that offer personalized assessments. As more women engage with healthcare providers regarding their menstrual health, the market is poised for sustained growth, reflecting a broader societal commitment to women's health and wellbeing.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Dysmenorrhea Testing Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Primary Dysmenorrhea Testing
• Secondary Dysmenorrhea Testing

Global Dysmenorrhea Testing Market Size by Type of Treatment & CAGR (2025-2032)

• Market Overview
• Market Overview
• Pain Relievers
• Hormonal Therapy
• Surgery

Global Dysmenorrhea Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Research Centers

Global Dysmenorrhea Testing Market Size & CAGR (2025-2032)

• North America (Product Type, Type of Treatment, End User)
  • US
  • Canada
• Europe (Product Type, Type of Treatment, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type of Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type of Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type of Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Global Pharma plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteomics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations